Atlas Trials

Optimize and Predict Antidepressant Efficacy for Patient With MDD Using Multi-omics Analysis and AI-predictive Tool

Clinical trial NCT06550037 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06550037
Sponsor
Alessio Fasano
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Major Depressive Disorder
Start date
2023-08-07
Primary completion
2027-04-01
Enrollment
350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.